Patenting costs cast a shadow on European biotech

Article Abstract:

The European Patent Office and the US Patent and Trademark Office have experienced an upsurge of patent applications from Europe. European biotech firms increasingly used patenting as a strategic tool and are continuing to do so, but high patenting costs cast a shadow on European biotech.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Building a strategy for maximizing intellectual property value

Article Abstract:

The managing of intellectual property (IP) requires the implementation of an IP strategy and standards that control the development of the IP portfolio. Strategy and tactics for managing an IP portfolio should infiltrate the biotech company from the business strategy to the product teams.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

The patent gamble: strategic insights for playing the worldwide patent game

Article Abstract:

Biotech companies seek international patent protection for their inventions to ensure long-term viability Methods to rein in an unruly patent program and begin the process of proactively managing the development of an international patent portfolio are discussed.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: